Clinical Trial Update: Radiolabeled Monoclonal Antibody Therapy and Etoposide Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Myelodysplastic Syndrome or Refractory Leukemia [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating radiolabeled monoclonal antibody therapy with etoposide followed by peripheral stem cell transplantation in patients with advanced myel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Myeloproliferative Neoplasms
• Myelodysplastic Syndromes

Drugs mentioned

• Etoposide (Etoposide)
• Radiolabeled Monoclonal Antibody Therapy

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 1 | Status: COMPLETED